Yoshimasa Nakazato
Papers
1
Total Citations
12
H-Index
1
About
Yoshimasa Nakazato is a urologic surgeon and researcher whose work focuses on improving oncological outcomes in prostate cancer, particularly through the use of robot-assisted radical prostatectomy (RARP). His research centers on refining preoperative risk stratification by integrating biomarkers and detailed biopsy pathology to guide surgical decision-making. In his most cited study (2017, 12 citations), Nakazato demonstrated that combining prostate-specific antigen density (PSAD) with biopsy core characteristics—such as the number and location of positive cores—significantly improves prediction of adverse pathology and biochemical recurrence in intermediate- to high-risk prostate cancer patients. This work provides urologists with practical tools to determine the need for extended resection or lymph node dissection, helping to personalize surgical aggressiveness. Nakazato’s contributions are particularly valuable for bridging the gap between standard clinical parameters and actionable surgical planning, offering a more nuanced approach to managing aggressive disease. His research continues to influence evidence-based protocols in urologic oncology, emphasizing the importance of integrating histopathological details with biomarker data to optimize patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1